Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Time to death and its Predictors among Adult TB/HIV Co-Infected Patients in Mizan Tepi University Teaching Hospital, South West Ethiopia

Wondimagegn Wondimu, Lamessa Dube, Teshome Kabeta
doi: https://doi.org/10.1101/19004234
Wondimagegn Wondimu
1Mizan Tepi University, College of Health Science, Department of Public Health, Mizan Aman, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wonde1983.ww@gmail.com
Lamessa Dube
2Jimma University, Faculty of Public Health, Department of Epidemiology, Jimma, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teshome Kabeta
2Jimma University, Faculty of Public Health, Department of Epidemiology, Jimma, Ethiopia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Tuberculosis (TB) and Human Immuno Deficiency Virus (HIV) co-infection represents a complex pathogenic scenario with synergistic effect and leads to about 300,000 HIV-associated TB deaths in the world in 2017. Despite this burden of death, time to death and its predictors among TB-HIV co-infected patient was not adequately studied; and the existing evidences are inconsistent. Therefore, this study was aimed to determine time to death and identify its predictors among adult TB/HIV co-infected patients.

Method Retrospective cohort study was conducted by reviewing registers of randomly selected 364 TB/HIV co-infected patients enrolled in health care from July 2, 2007 up to July 1, 2017 at Mizan Tepi University Teaching Hospital. The hospital was located in Bench Maji Zone, South West Ethiopia. Data were collected from March 1 through 31, 2018, entered to Epi data 3.1 and exported to SPSS version 21. Each patient was followed from date of TB treatment initiation till death, loss to follow up and treatment completed. On the other hand, events other than death were considered as censored. After checking the proportional hazard model assumption, Cox-regression was used to identify the predictors. In bivariable analyses, P-value≤0.25 was used to identify candidate variables for multivariable analysis. The 95% CI of hazard ratio (HR) with respective P-value <0.05 was used to declare significance in the final model.

Result All the 364 patients were followed for 1,654 person months. There were 83 (22.8%) deaths and most 38 (45.8%) were occurring within the first two months of anti-TB treatment initiation. The overall incidence rate and median survival time were 5.02 per 100 person months (95% CI: 4.05, 6.22) and 10 months respectively. Statistically significant better survival was observed among patients: with CD4 ≥ 200 cells/mm3 (P<0.001), who had a history of cotrimoxazole preventive therapy (CPT) use (P<0.001), who disclose their HIV status (P<0.001) and with working functional status (P<0.001). Not using CPT (adjusted hazard ratio [AHR] =1.72; P=0.023), bedridden functional status (AHR=2.55; P=0.007), not disclosing HIV status (AHR=4.03; P<0.001) and CD4 < 200 cells/mm3 (AHR=6.05; P<0.001) were predictors of time to death among TB/HIV co-infected patients.

Conclusion The median survival time was 10 months and poor survival was associated with low CD4 count, not using CPT, not disclosing HIV status and having bedridden functional status. Close monitoring of bedridden and low CD4 count patients, prompt CPT initiation and encouraging HIV status disclosure are recommended.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The fund for this research was covered by Jimma University

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Not Applicable

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Not Applicable

Footnotes

  • dubelamessa{at}yahoo.com

  • tka1204{at}gmail.com

Data Availability

All data are available from corresponding author for any reasonable requests.

https://mail.google.com/wonde1983.ww@gmail.com

  • List of abbreviations

    AHR
    Adjusted Hazard Ratio
    AIDS
    Acquired Immuno Deficiency Syndrome
    AOR
    Adjusted Odds Ratio
    ART
    Anti-Retro Viral Therapy
    BMI
    Body Mass Index
    CD4
    Cluster of Differentiation 4
    CI
    Confidence Interval
    CPT
    Cotrimoxazole Preventive Therapy
    HIV
    Human Immuno Deficiency Virus
    HR
    Hazard Ratio
    IRB
    Institutional Review Board
    OIs
    Opportunistic Infections
    PLWHA
    Peoples Living With HIV/IDS
    TB
    Tuberculosis
    UNAIDS
    The joint United Nations Programme on HIV/AIDS
    WHO
    World Health Organization
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted August 07, 2019.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Time to death and its Predictors among Adult TB/HIV Co-Infected Patients in Mizan Tepi University Teaching Hospital, South West Ethiopia
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Time to death and its Predictors among Adult TB/HIV Co-Infected Patients in Mizan Tepi University Teaching Hospital, South West Ethiopia
    Wondimagegn Wondimu, Lamessa Dube, Teshome Kabeta
    medRxiv 19004234; doi: https://doi.org/10.1101/19004234
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Time to death and its Predictors among Adult TB/HIV Co-Infected Patients in Mizan Tepi University Teaching Hospital, South West Ethiopia
    Wondimagegn Wondimu, Lamessa Dube, Teshome Kabeta
    medRxiv 19004234; doi: https://doi.org/10.1101/19004234

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • HIV/AIDS
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (168)
    • Anesthesia (50)
    • Cardiovascular Medicine (448)
    • Dentistry and Oral Medicine (80)
    • Dermatology (55)
    • Emergency Medicine (157)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
    • Epidemiology (5219)
    • Forensic Medicine (3)
    • Gastroenterology (195)
    • Genetic and Genomic Medicine (750)
    • Geriatric Medicine (77)
    • Health Economics (212)
    • Health Informatics (694)
    • Health Policy (352)
    • Health Systems and Quality Improvement (223)
    • Hematology (99)
    • HIV/AIDS (162)
    • Infectious Diseases (except HIV/AIDS) (5823)
    • Intensive Care and Critical Care Medicine (356)
    • Medical Education (102)
    • Medical Ethics (25)
    • Nephrology (80)
    • Neurology (758)
    • Nursing (43)
    • Nutrition (129)
    • Obstetrics and Gynecology (141)
    • Occupational and Environmental Health (231)
    • Oncology (475)
    • Ophthalmology (149)
    • Orthopedics (38)
    • Otolaryngology (94)
    • Pain Medicine (39)
    • Palliative Medicine (19)
    • Pathology (139)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (136)
    • Primary Care Research (96)
    • Psychiatry and Clinical Psychology (854)
    • Public and Global Health (1995)
    • Radiology and Imaging (345)
    • Rehabilitation Medicine and Physical Therapy (157)
    • Respiratory Medicine (283)
    • Rheumatology (93)
    • Sexual and Reproductive Health (72)
    • Sports Medicine (75)
    • Surgery (108)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)